Roundtable: The State of Hub Services in 2026

Author(s)Aimee Bugosh , Josh Marsh, Kristine McGaughey

Four patient services veterans on what's driving hub transitions in 2026, the digital tools reshaping how support is delivered, and what manufacturers need to get right to keep patients on therapy.

Pharma's investment in hub and patient access support services has grown sharply alongside the specialty pipeline. The global market for these services, valued at approximately $3.55 billion in 2025, is projected to nearly triple to $10 billion by 2035 as stakeholders navigate an increasingly complex landscape of high-cost therapies, payer friction, and more.¹

Related to this article

October 9th, 2026

LogiPharma USA 2026: Where Cold Chain Expertise Gaps Become Product Risk

At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.

October 9th, 2026

Why Securing Pharma Freight Starts With Broker and Carrier SOPs

Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner SOPs matter.

October 8th, 2026

Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens

At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.

October 8th, 2026

Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer's $2.2B Ohio Site

In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.

October 7th, 2026

Pharma Rethinks Supply Chain Planning as Disruptions Mount

Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.

Judge's wooden gavel and USA flag | © BillionPhotos.com - stock.adobe.com 854163237

October 7th, 2026

Why PhRMA Sued to Block Medicare's GLOBE Pricing Model

PhRMA's lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.

October 7th, 2026

Why Pharma Is Automating for Resilience

At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.

October 6th, 2026

LogiPharma USA 2026: Data Readiness Must Come Before AI

At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.